齐齐哈尔市某高校人群血清乙型肝炎病毒流行病学调查*

doi:10.3969/j.issn.1672-5069.2016.05.023

Abstract

Nie Yuntian, Guo Lina, Liu Shubin, et al.. An epidemiological survey of hepatitis B virus infection in the population of a university in Qigihar[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 601-602.

References

[1] 聂云天,刘伯阳,王琪. 感染鸭乙型肝炎病毒外周血CD4 + 和CD8 + T淋巴细胞水平变化. 实用肝脏病杂志,2015,18（3）:256-258.
[2] 崔富强.中国2005-2010年报告乙型病毒性肝炎发病分析.中国疫苗和免疫,2011,17（6）:483-486.
[3] Ng KP,Ngeow YF,Kr MR.Hepatitis B seroprevalence among university of Malaya students in the post universal infant vaccination era. Med J Malaysia,2013,68（2）:144-147.
[4] 凌媛,黄水群. 广西某高校新生乙型肝炎流行病学调查. 中国校医,2012,26（2）:106-107.
[5] 李启新.中国大学生乙型肝炎的流行和防控研究.医学动物防治,2013,29（4）:397-399.
[6] 周光雄,罗述斌,李欣钦,等. 高校新生乙型肝炎病毒血清学标志物结果分析. 国际医药卫生导报,2005,11（6）:117-118.
[7] 彭扬凤,王泽玲. 株洲某高校人群乙型肝炎血清流行病学调查.实用预防医学,2006,13（4）:919.
[8] 王伯庆,薛峰,佟庆,等. 抗病毒治疗对乙型肝炎相关肝癌根治术后复发和生存的影响. 实用肝脏病杂志,2015,18（2）:132-135.
[9] 周伟平,尹磊,吴孟超. 抗病毒治疗在 HBV 相关肝癌综合治疗中的作用. 实用肝脏病杂志,2015,18（2）:115-117.
[10] 陈建宏,刘妍,李进,等. 隐匿性乙型肝炎病毒感染研究进展.实用肝脏病杂志,2015,18（2）:205-208.
[11] 丁俊琪,姚建华,马陈斌,等. 慢性乙型肝炎患者血清HBeAg水平对阿德福韦酯抗病毒疗效的影响.实用肝脏病杂志,2015,18（4）:109-110.
[12] 郑盛,唐映梅,杨晋辉. 血清HBsAg 滴度监测对恩替卡韦治疗 HBeAg阳性慢性乙型肝炎患者应答反应的预测价值.实用肝脏病杂志,2014,17（5）:502-506.
[13] 占国清,谭华炳,李芳,等. α-干扰素治疗慢性乙型肝炎完全应答后5年随访报告.实用肝脏病杂志,2014,17（4）:380-383.
[14] 江杰,黄新颜,王利红,等. HBV感染者病毒基因型分布特点及其与干扰素疗效的关系. 实用肝脏病杂志,2014,17（3）:299-300.
[15] 李晓东,徐东平. HBV相关慢加急性肝衰竭免疫病理发病机制研究进展. 实用肝脏病杂志,2015,18（3）:317-320.
[16] 林潮双,顾琳. 广州某高等医学院校研究生乙型肝炎病毒感染的调查分析. 中华医院感染学杂志,2009,19（1）:43-45.
[17] 王松贤. 慢性乙型肝炎患者肝组织学检查的意义.实用肝脏病杂志,2014,17（3）:297-298.

An epidemiological survey of hepatitis B virus infection in the population of a university in Qigihar

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[8]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[9]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[10]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[11]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[12]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[13]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[14]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[15]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.